Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
Manraj SinghKrishnakumar ThankappanDeepak BalasubramanianVijay PillaiVivek ShettyVidyabhushan RangappaNaveen Hedne ChandrasekharVikram KekatpureMoni Abraham KuriakoseArvind KrishnamurthyArun MitraPattatheyil ArunPrateek JainSubramania IyerNarayanan Gopalakrishna IyerNarayana Subramaniamnull nullPublished in: Head & neck (2022)
In advanced OSCC, stratification with histopathologic risk factors can predict survival even in maximally treated patients; adjuvant therapies are unable to entirely mitigate this risk. Incorporation of adverse features into future editions of TNM can improve precision in staging and identify candidates for treatment escalation.